Fresh Tracks Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fresh Tracks Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q4 2023.
  • Fresh Tracks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $267K, a 45.5% decline year-over-year.
  • Fresh Tracks Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $1.92M, a 11% decline year-over-year.
  • Fresh Tracks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.92M, a 11% decline from 2022.
  • Fresh Tracks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.16M, a 4.73% decline from 2021.
  • Fresh Tracks Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.26M, a 13.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.92M $267K -$223K -45.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 $2.14M $863K +$324K +60.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.82M $410K -$166K -28.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $1.98M $379K -$172K -31.2% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $2.16M $490K -$106K -17.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $2.26M $539K -$238K -30.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.5M $576K +$155K +36.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $2.35M $551K +$82K +17.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $2.26M $596K +$12K +2.06% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.25M $777K +$224K +40.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.03M $421K -$32K -7.06% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-09-01
Q1 2021 $2.06M $469K +$66K +16.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.99M $584K +$59K +11.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $1.93M $553K +$229K +70.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.71M $453K +$154K +51.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.55M $403K +$19K +4.95% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $1.53M $525K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $324K +$173K +115% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $299K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $384K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 $151K -$32K -17.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q4 2017 $800K $189K -$7K -3.57% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $807K $183K -$30K -14.1% Jul 1, 2017 Sep 30, 2017 10-Q 2017-10-24
Q2 2017 $837K $197K -$81K -29.1% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $918K $231K -$82K -26.2% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $1M $196K -$172K -46.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $1.17M $213K -$224K -51.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-24
Q2 2016 $1.4M $278K -$248K -47.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $1.64M $313K -$258K -45.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.9M $368K -$340K -48% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-15
Q3 2015 $2.24M $437K -$293K -40.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $2.54M $526K -$358K -40.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $2.89M $571K -$266K -31.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $3.16M $708K -$72K -9.23% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-10
Q3 2014 $3.23M $730K -$2K -0.27% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-30
Q2 2014 $3.23M $884K +$68K +8.33% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $3.17M $837K -$301K -26.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $3.47M $780K +$68K +9.55% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $3.4M $732K -$3K -0.41% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 $3.4M $816K -$107K -11.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $3.51M $1.14M +$218K +23.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $3.29M $712K Oct 1, 2012 Dec 31, 2012 10-K 2015-02-26
Q3 2012 $735K -$12K -1.61% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $923K +$108K +13.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $920K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q3 2011 $747K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $815K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.